EDIT Q2 2025 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$256M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+597.5% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$52M-1440.6% margin

Net Income

-$53M-1487.8% margin

EPS (Diluted)

$-0.63

QoQ Revenue Growth

-23.2%

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$50M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$211M

Total Liabilities

$191M

Stockholders' Equity

$19M

Cash & Equivalents

$139M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$513,000	+597.5%
Gross Profit	$4M	-$907,000	+494.5%
Operating Income	-$52M	-$72M	+28.3%
Net Income	-$53M	-$68M	+21.3%

Revenue Segments

Reportable Segment

$4M100%